Brent Guerisoli sold $131k of PNTG
Chief Executive Officer at Pennant Group, Inc.. 3,159 shares at an average of $41.57, traded Jul 10, 2026, filed Jul 14, 2026.
Score components
- +25RoleCEO
- +11Trade size$131k at market
- 0Share of holdings soldSold 3.0% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001838360-26-000005, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 10, 2026 | MOption exercise Common Stock10b5-1 | +6,248 | $4.54 | $28k | 106,988 | Jul 14, 2026 |
| Jul 10, 2026 | SOpen-market sale Common Stock10b5-1 | -3,159 | $41.57 | $131k | 103,829 | Jul 14, 2026 |
| Jul 10, 2026 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -6,248 | $4.54 | $28k | 0 | Jul 14, 2026 |
Related signals
Other insiders at Pennant Group, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 17Weak | Pennant Group, Inc. | Kirk Sterling Cheney EVP, GC and Corp Secy | $54k 1,393 shares | -7% | |
| 31Weak | Pennant Group, Inc. | Brent Guerisoli Chief Executive Officer | $165k 4,285 shares | -4% | |
| 17Weak | Pennant Group, Inc. | Jason Paul Steik Chief Clinical Officer | $54k 1,394 shares | -8% | |
| 1Weak | Pennant Group, Inc. | Brent Guerisoli Chief Executive Officer | $128k 3,165 shares | -3% | |
| 1Weak | Pennant Group, Inc. | Brent Guerisoli Chief Executive Officer | $158k 4,508 shares | -5% | |
| 3Weak | Pennant Group, Inc. | Kirk Sterling Cheney EVP, GC and Corp Secy | $21k 880 shares | -6% | |
| 23Weak | Pennant Group, Inc. | Brent Guerisoli Chief Executive Officer | $93k 3,995 shares | -5% | |
| 16Weak | PNTGsell Pennant Group, Inc. | JoAnne Stringfield director | $147k 5,000 shares | -14% | |
| 0Weak | Pennant Group, Inc. | JoAnne Stringfield director | $17k 665 shares | -2% | |
| 0Weak | Pennant Group, Inc. | JoAnne Stringfield director | $13k 380 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.